Skip to content

MENFIT POWER TRIAL 2020 Prospective longitudinal clinical Survey regarding the application of MENFIT POWER CAPS

MENFIT POWER TRIAL 2020 Prospective longitudinal clinical Survey regarding the application of MENFIT POWER CAPS - MENFIT POWER TRIAL 2020

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00024119
Enrollment
100
Registered
2021-05-19
Start date
2021-06-15
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Men with erectile dysfunction

Interventions

Group 1: Men with moderate or mild erectile dysfunction, review of clinical efficacy and safety of Menfit Power Caps
data sources: questionnaires for the primary outcome. Primary outcome measure: international prostata symptom score (IPSS)
- erection hardness score (EHS)
- international index of erectile function (IPEF-5)
- aging male syndrom (AMS)

Sponsors

MENFIT AG
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
30 Years to 70 Years

Inclusion criteria

Inclusion criteria: Men with mild erectile dysfunction (IIEF-5 17-21 points) and moderate ED (IIEF-5 12-16 points) Men with mild to moderate symptoms of ED (IIEF-5 12-21 pts)

Exclusion criteria

Exclusion criteria: Taking PED-5 inhibitors; existing testosterone substitution, aphrodisiacs

Design outcomes

Primary

MeasureTime frame
Questionnaire: Internationaler Prostata Symptomen Score (IPSS) Erection Hardness Score (EHS) International Index of Erectile Function (IIEF-5) Aging Male Syndrom (AMS) Expiry dates: 4 dates: The same questionnaire is filled out four times. After receiving all questionnaires, we will evaluate and analyze them in order to determine the influence or improvement on the health of the test subjects.

Countries

Germany

Contacts

Public ContactLudwig Rinnab

Praxis für Urologie und Männergesundheit Neu-Ulm

ludwig@dr-rinnab.de0731-78300

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026